This service provides chemical synthesis of lead compounds for use in additional drug development studies. Compounds must previously have been successfully synthesized to be candidates for this service. Synthesis of new analogs is not supported.
The current contractor for this service is Starks Associates, Inc., Buffalo, New York.
Last Updated July 07, 2009